drugset / Trial / NCT00266578
A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is assessing the efficacy of swallowed Flovent® vs. placebo for the treatment of eosinophilic esophagitis (EE).
Timeline
- Start
- 2002-10
- Primary completion
- 2006-11
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | — | — |